Humana (HUM) — insider trading
Health Care · NYSE
Humana (HUM) has 12 reported SEC Form 4 insider transactions in our data (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | HILZINGER KURT J | Director | Grant / award / vesting (derivative) | 233 | $392.32 | $91.4K | Form 4 |
| 2026-05-01 | Martin Aaron | Officer (President, Medicare Advantage) | Grant / award / vesting | 8,206 | $0.00 | $0 | Form 4 |
| 2026-05-01 | Shetty Sanjay K | Officer (President, CenterWell) | Grant / award / vesting | 9,945 | $0.00 | $0 | Form 4 |
| 2026-05-01 | Ventura Joseph C | Officer (Chief Legal Officer) | Grant / award / vesting | 10,318 | $0.00 | $0 | Form 4 |
| 2026-05-01 | Field Robert Stuart | Director | Grant / award / vesting | 852 | $0.00 | $0 | Form 4 |
| 2026-05-01 | O'Hara Michelle A. | Officer (Chief Human Resources Officer) | Grant / award / vesting | 10,485 | $0.00 | $0 | Form 4 |
| 2026-05-01 | Rechtin James A. | Officer (President & CEO) | Grant / award / vesting | 35,633 | $0.00 | $0 | Form 4 |
| 2026-05-01 | Dintenfass David | Officer (President, Enterprise Growth) | Grant / award / vesting | 11,273 | $0.00 | $0 | Form 4 |
| 2026-05-01 | Mehta Japan | Officer (Chief Information Officer) | Grant / award / vesting | 9,448 | $0.00 | $0 | Form 4 |
| 2026-05-01 | Mellet Celeste | Officer (Chief Financial Officer) | Grant / award / vesting | 15,387 | $0.00 | $0 | Form 4 |
| 2026-04-01 | Shetty Sanjay K | Officer (President, CenterWell) | Shares withheld for taxes / exercise cost | 401 | $175.44 | $70.4K | Form 4 |
| 2026-04-01 | Shetty Sanjay K | Officer (President, CenterWell) | Option exercise / conversion | 887 | $0.00 | $0 | Form 4 |
Ask the chat about HUM's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Humana (HUM).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.